http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-110232978-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ca46be4e68fa1f5a8b2ef4ab654c490a
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16H70-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16B20-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16B20-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16B25-10
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G16B20-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G16B20-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G16B25-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G16H70-40
filingDate 2019-06-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cb6256f346272f9e6f7626368ee5f315
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7048353b1cbfea7b77ba731ff51670d9
publicationDate 2019-09-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-110232978-A
titleOfInvention Multidimensional network-based drug prediction method for cancer cell lines
abstract The invention discloses a method for predicting cancer cell line therapeutic drugs based on a multi-dimensional network, which mainly solves the problem of low accuracy rate of prediction results of cancer cell line therapeutic drugs in the prior art. The scheme is: download the data of n cancer cell lines, and construct the cancer cell line similarity network; download the data of m drugs, and construct the drug similarity network; in the cancer cell line similarity network, use the diffusion component analysis algorithm to calculate The low-dimensional eigenvector matrix of n cancer cell lines; in the drug similarity network, the low-dimensional eigenvector matrix of m drugs is calculated by using the diffusion component analysis algorithm; the logistic regression model of drug response is obtained; the calculation of drugs and cancer cell lines The scores of the sensitivity relationship between them are used to judge whether the drug has a therapeutic effect on the cancer cell line by the score of the sensitivity relationship. The invention improves the accuracy rate of the prediction result of the cancer cell line therapeutic drug, and can be used for the prediction experiment of the cancer's response to the drug.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-112768089-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-114255886-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-112289389-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-112635080-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-110867254-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2022214036-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-115206421-A
priorityDate 2019-06-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2010056893-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2908132-A2
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419475193
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419552268
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414652573
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426228482
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID16722836
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID44182295
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID216239
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11626560

Total number of triples: 35.